Shattuck Labs (STTK) Provides Company Update and Announces SL-325
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
H.C. Wainwright Downgrades Shattuck Labs (STTK) to Neutral
October 1, 2024 10:32 AM EDTH.C. Wainwright analyst Joseph Pantginis downgraded Shattuck Labs (NASDAQ: STTK) from Buy to Neutral.
The analyst comments "Despite encouraging early clinical data; shifting gears away from CD47. This morning, Shattuck announced that following a strategic review of its pipeline and its amassed CD47 data to date in... More
H.C. Wainwright Downgrades Shattuck Labs (STTK) to Neutral
October 1, 2024 10:32 AM EDTH.C. Wainwright analyst Joseph Pantginis downgraded Shattuck Labs (NASDAQ: STTK) from Buy to Neutral.
The analyst comments "Despite encouraging early clinical data; shifting gears away from CD47. This morning, Shattuck announced that following a strategic review of its pipeline and its amassed CD47 data to date in... More
